Switching to DTG/3TC fixed-dose combination (FDC) Is non-inferior to continuing a TAF-based regimen in maintaining virologic suppression through 48 weeks (TANGO Study) - J. Van Wyk; F. Ajana; F. Bisshop; S. De Wit; Y. Osiyemi; J. Portilla; J. Routy; C. Wyen; M. Ait-Khaled; M. Nascimento; K. Pappa; R. Wang; et al. (Elsevier, 2020)